Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 825.79B, Eli Lilly(LLY) trades at $870.10. The stock has a price-to-earnings ratio of 38.08 and currently yields dividends of 71.3%.
During the trading session on 2026-04-29, Eli Lilly(LLY) shares reached a daily high of $870.10 and a low of $870.10. At a current price of $870.10, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 6.43K, versus its average volume of 3.08M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
The average one-year price target for Eli Lilly and (SWX:LLY) has been revised to CHF 997,26 / share. This is an increase of 24.41% from the prior estimate of C...
Eli Lilly (NYSE:LLY) has entered a multi billion dollar partnership with Profluent to develop AI designed enzymes for genetic medicines. The collaboration focu...
(RTTNews) - Profluent, an AI-first protein design company, on Tuesday announced a multi-program partnership with Eli Lilly and Company worth up ?to $2.25 billio...
Analyst ratings
82%
of 34 ratingsMore LLY News
Key Points Eli Lilly is best known for its work in the weight loss market. The company has billion-dollar drugs in other areas. The drugmaker continues to ex...
Eli Lilly (NYSE:LLY) agreed to acquire Ajax Therapeutics in a $2.3b transaction, its second oncology deal this month. The acquisition adds AJ1-11095, a clinica...
Pharmaceutical giant Eli Lilly (LLY) remains on a buying spree, announcing that it is acquiring cancer drug developer Ajax Therapeutics for $2.3 billion in cash...
Biotech and Pharma As Investors Focus on Lilly’s Foundayo, They May Be Overlooking Another Key Catalyst In this article LLY NVO Eli Lilly is exploring a combina...
Eli Lilly said Ajax is developing next-generation Janus kinase, or JAK, inhibitors for patients with myeloproliferative neoplasms. Mike Blake / Reuters Eli Lil...
Eli Lilly shares slid nearly 4% Friday after early data on prescription volume for its new weight loss pill signaled it’s off to a slow start. Lilly began sell...
Technology Battle Of The Weight-Loss Pills Continues With A Shocking Twist Licensing Eli Lilly (LLY) stock skidded early Friday as Novo Nordisk's (NVO) Wegovy p...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.